Alstom: to test Coradia iLint in Netherlands
(CercleFinance.com) - Alstom will, for the first time in the Netherlands, test Coradia iLint, the first hydrogen fuel cell passenger train in the world.
The tests are scheduled for the first three months of 2020 on the Groningen-Leeuwarden line, at a maximum speed of 140 km/h. They are set to last for about two weeks.
"The ambition is to organise the test during the first quarter of 2020. The objective is to demonstrate that hydrogen fuel cell technology is an appropriate way to achieve zero-emission rail traffic on non-electrified lines in the Netherlands where there are currently diesel trains running," the group said.
"Alstom is committed to developing and implementing mobility solutions that permit not only the emergence of fully sustainable transport systems but also help drive the broader energy transition. We look forward to demonstrating what has already been proven in Germany - that hydrogen represents a highly suitable way forward in both cases," said Bernard Belvaux, Managing Director of Alstom Benelux.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The tests are scheduled for the first three months of 2020 on the Groningen-Leeuwarden line, at a maximum speed of 140 km/h. They are set to last for about two weeks.
"The ambition is to organise the test during the first quarter of 2020. The objective is to demonstrate that hydrogen fuel cell technology is an appropriate way to achieve zero-emission rail traffic on non-electrified lines in the Netherlands where there are currently diesel trains running," the group said.
"Alstom is committed to developing and implementing mobility solutions that permit not only the emergence of fully sustainable transport systems but also help drive the broader energy transition. We look forward to demonstrating what has already been proven in Germany - that hydrogen represents a highly suitable way forward in both cases," said Bernard Belvaux, Managing Director of Alstom Benelux.
Copyright (c) 2019 CercleFinance.com. All rights reserved.